The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)propionamide ID: ALA4867516
PubChem CID: 164621822
Max Phase: Preclinical
Molecular Formula: C24H28N6O2
Molecular Weight: 432.53
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(=O)Nc1cccc(Oc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1
Standard InChI: InChI=1S/C24H28N6O2/c1-3-22(31)26-19-5-4-6-21(17-19)32-23-11-12-25-24(28-23)27-18-7-9-20(10-8-18)30-15-13-29(2)14-16-30/h4-12,17H,3,13-16H2,1-2H3,(H,26,31)(H,25,27,28)
Standard InChI Key: BGAVHUGJSGAGCH-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
39.5746 -10.3717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.5734 -11.1912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2815 -11.6002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9911 -11.1908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9883 -10.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2797 -9.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8654 -11.5993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1580 -11.1901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6995 -11.5982 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.4066 -11.1885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1632 -10.3730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4567 -9.9640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7476 -10.3720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7496 -11.1935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4568 -11.5988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1116 -11.5964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8182 -11.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8173 -10.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1040 -9.9620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4003 -10.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5263 -11.5953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.2336 -11.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9417 -11.5937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6490 -11.1844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2327 -10.3687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0397 -9.9638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0393 -9.1466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3322 -10.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6243 -9.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3313 -8.7384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6239 -9.1474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9159 -8.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
4 9 1 0
9 10 1 0
8 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 8 1 0
10 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 10 1 0
17 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
22 25 2 0
13 26 1 0
26 27 1 0
26 28 1 0
28 29 1 0
27 30 1 0
29 31 1 0
31 30 1 0
31 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 432.53Molecular Weight (Monoisotopic): 432.2274AlogP: 4.11#Rotatable Bonds: 7Polar Surface Area: 82.62Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.65CX Basic pKa: 7.96CX LogP: 4.16CX LogD: 3.49Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.58Np Likeness Score: -1.91
References 1. Yang H, Wang X, Wang C, Yin F, Qu L, Shi C, Zhao J, Li S, Ji L, Peng W, Luo H, Cheng M, Kong L.. (2021) Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer., 210 [PMID:33310286 ] [10.1016/j.ejmech.2020.113080 ]